Evidence map›Paper›PMID 35057828›Full record

ArticleJournal of ovarian research2022

The boosting effects of melatonin on the expression of related genes to oocyte maturation and antioxidant pathways: a polycystic ovary syndrome- mouse model.

Fatemeh Nikmard, Elham Hosseini, Mehrdad Bakhtiyari, Mahnaz Ashrafi, Fardin Amidi, Reza Aflatoonian

Open access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Melatonin Supplementation duringAnimals : an open access journal from MDPI · 2023
    Article
  18. The Effect of AlteredInternational journal of fertility & sterility · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Fatemeh Nikmard *Anatomy Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Elham Hosseini *Department of Obstetrics and Gynecology, Mousavi Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Mehrdad BakhtiyariAnatomy Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Mehr_bakhtiyari@yahoo.com.
Mahnaz AshrafiDepartment of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Fardin AmidiAnatomy Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Reza AflatoonianDepartment of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. R.aflatoonian@royaninstitute.org.
Academic Center for Education, Culture and Research · IRIran University of Medical Sciences · IRTehran University of Medical Sciences · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelatonin, as a free radical scavenger exhibiting genomic actions, regulates the antioxidant genes expression and apoptosis mechanisms. In polycystic ovary syndrome (PCOS) patients, an imbalance between free radicals and antioxidants in follicular fluid leads to oxidative stress, aberrant folliculogenesis, and intrinsic defects in PCOS oocytes. In this experimental mouse model study, oocytes of PCOS and the control groups were cultured in different melatonin concentrations (10

resultsGdf9 and Bmp15, Gpx1 and Sod1 were up-regulated in PCOS and control oocytes cultured in all melatonin concentrations compared to those cultured in IVM basal medium (P < 0.05). A significant decrease in the total ROS level was observed in all groups cultured in the supplemented cultures. Melatonin increased Bcl2 and decreased Bax gene expression in PCOS and control oocytes compared to non-treated oocytes.

conclusionsMelatonin increased antioxidant gene expression and regulated the apoptosis pathway, effectively reducing the adverse effects of culture conditions on PCOS oocytes. Furthermore, it influenced the expression of oocyte maturation-related genes in PCOS, providing valuable support during the IVM process.

Indexed as

AnimalsAntioxidantsApoptosisbcl-2-Associated X ProteinBone Morphogenetic Protein 15DehydroepiandrosteroneDisease Models, AnimalFemaleGlutathione PeroxidaseGlutathione Peroxidase GPX1Growth Differentiation Factor 9In Vitro Oocyte Maturation TechniquesMelatoninMiceOocytesOogenesisAntioxidantsBax protein, mousebcl-2-Associated X ProteinBcl2 protein, mouseBmp15 protein, mouseBone Morphogenetic Protein 15DehydroepiandrosteroneGdf9 protein, mouseGlutathione PeroxidaseGlutathione Peroxidase GPX1Gpx1 protein, mouseGrowth Differentiation Factor 9MelatoninProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesSod1 protein, mouseSuperoxide Dismutase-1AntioxidantIn-vitro maturationMelatoninPCOS

Identifiers

PMID35057828
PMCPMC8781027
OpenAlexW4205580746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.